gms | German Medical Science

25th Annual Meeting of the German Retina Society

German Retina Society

01.06. - 02.06.2012, Münster

Intraarterial chemotherapy in the treatment of retinoblastoma

Meeting Abstract

  • Gregor D. Willerding - Augenklinik der Charité CBF Berlin
  • E. Foert - DRK Kliniken Mitte, Berlin
  • N. Lakotka - Augenklinik der Charité CBF Berlin
  • A.M. Joussen - Augenklinik der Charité CBF Berlin

German Retina Society. 25th Annual Conference of the German Retina Society. Münster, 01.-02.06.2012. Düsseldorf: German Medical Science GMS Publishing House; 2012. Doc12rg21

DOI: 10.3205/12rg21, URN: urn:nbn:de:0183-12rg214

This is the translated version of the article.
The original version can be found at: http://www.egms.de/de/meetings/rg2012/12rg21.shtml

Published: May 30, 2012

© 2012 Willerding et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en). You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.


Outline

Text

Background: Intraarterial Chemotherapy (IAC) has gained some popularity in the treatment of retinoblastoma.

Method: retrospective case series of five patients with a follow up of more than 6 months.

Result: All cases (four unilateral, 1 bilateral) were classified as group D (ICRB). IAC was primary treatment in all cases. Globe preservation was achieved in 4 cases. Additional therapies included cryotherapy (5 cases), laser treatment (4 cases) and brachytherapy (3 cases). Ischemic/toxic chorioretinopathy as the main complication occured in one case.

Discussion: IAC was successfully used as a globe-sparing approach in the majority of patients.